NEUROCEA
Neurocea Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders. Neurocea’s lead product successfully completed Phase 2 clinical trials for treatment of L-Dopa induced dyskinesias (LIDs) in Parkinson’s patients
NEUROCEA
Industry:
Biopharma Biotechnology Health Care
Founded:
2012-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.neurocea.com
Total Employee:
1+
Status:
Active
Contact:
(650) 279-7028
Total Funding:
0
Technology used in webpage:
SPF Euro Google Apps For Business Google Google Cloud ENom DNS
Similar Organizations
CannaPowder
CannaPowder is a bio-pharma company dedicated to developing and applying innovative technology.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Memphasys Ltd
Memphasys Ltd is a bio-separations company developing and commercialising innovative separation techniques.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
QLT Inc
QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
ZenCapsule
ZenCapsule is a company dedicated to developing advanced drug delivery systems that enhance treatment efficacy.
Founder
